nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—CYP2D6—Lomustine—brain cancer	0.138	0.178	CbGbCtD
Domperidone—CYP1A2—Carmustine—brain cancer	0.137	0.176	CbGbCtD
Domperidone—CYP2D6—Hydroxyurea—brain cancer	0.105	0.135	CbGbCtD
Domperidone—CYP3A4—Temozolomide—brain cancer	0.103	0.133	CbGbCtD
Domperidone—CYP3A4—Lomustine—brain cancer	0.088	0.113	CbGbCtD
Domperidone—CYP3A5—Etoposide—brain cancer	0.0545	0.0703	CbGbCtD
Domperidone—CYP2C8—Etoposide—brain cancer	0.0524	0.0676	CbGbCtD
Domperidone—CYP1A2—Etoposide—brain cancer	0.0406	0.0523	CbGbCtD
Domperidone—ABCB1—Etoposide—brain cancer	0.0355	0.0457	CbGbCtD
Domperidone—CYP3A4—Etoposide—brain cancer	0.0213	0.0274	CbGbCtD
Domperidone—DRD3—telencephalic ventricle—brain cancer	0.00825	0.191	CbGeAlD
Domperidone—Disorientation—Lomustine—brain cancer	0.00402	0.0421	CcSEcCtD
Domperidone—Lethargy—Lomustine—brain cancer	0.00367	0.0384	CcSEcCtD
Domperidone—DRD2—telencephalic ventricle—brain cancer	0.00349	0.0808	CbGeAlD
Domperidone—Gynaecomastia—Procarbazine—brain cancer	0.00281	0.0294	CcSEcCtD
Domperidone—Stomatitis—Lomustine—brain cancer	0.0027	0.0283	CcSEcCtD
Domperidone—Disorientation—Procarbazine—brain cancer	0.00255	0.0267	CcSEcCtD
Domperidone—Lethargy—Procarbazine—brain cancer	0.00233	0.0244	CcSEcCtD
Domperidone—Breast pain—Temozolomide—brain cancer	0.00218	0.0228	CcSEcCtD
Domperidone—DRD2—ganglion—brain cancer	0.00217	0.0503	CbGeAlD
Domperidone—Disorientation—Hydroxyurea—brain cancer	0.00197	0.0207	CcSEcCtD
Domperidone—Pollakiuria—Procarbazine—brain cancer	0.00182	0.0191	CcSEcCtD
Domperidone—Gynaecomastia—Carmustine—brain cancer	0.00176	0.0184	CcSEcCtD
Domperidone—Drowsiness—Procarbazine—brain cancer	0.00176	0.0184	CcSEcCtD
Domperidone—Stomatitis—Procarbazine—brain cancer	0.00171	0.0179	CcSEcCtD
Domperidone—DRD2—hindbrain—brain cancer	0.00165	0.0382	CbGeAlD
Domperidone—Hot flush—Temozolomide—brain cancer	0.00147	0.0154	CcSEcCtD
Domperidone—Menopausal symptoms—Temozolomide—brain cancer	0.00146	0.0153	CcSEcCtD
Domperidone—Thirst—Temozolomide—brain cancer	0.00145	0.0152	CcSEcCtD
Domperidone—Dysuria—Hydroxyurea—brain cancer	0.00143	0.0149	CcSEcCtD
Domperidone—Arrhythmia—Procarbazine—brain cancer	0.00141	0.0148	CcSEcCtD
Domperidone—Drowsiness—Hydroxyurea—brain cancer	0.00136	0.0142	CcSEcCtD
Domperidone—Tension—Procarbazine—brain cancer	0.00135	0.0141	CcSEcCtD
Domperidone—Nervousness—Procarbazine—brain cancer	0.00133	0.014	CcSEcCtD
Domperidone—Stomatitis—Hydroxyurea—brain cancer	0.00133	0.0139	CcSEcCtD
Domperidone—DRD3—head—brain cancer	0.00123	0.0286	CbGeAlD
Domperidone—CYP3A7—endocrine gland—brain cancer	0.00122	0.0283	CbGeAlD
Domperidone—Dry mouth—Procarbazine—brain cancer	0.00114	0.012	CcSEcCtD
Domperidone—DRD3—central nervous system—brain cancer	0.00113	0.0261	CbGeAlD
Domperidone—Vomiting—Lomustine—brain cancer	0.00112	0.0118	CcSEcCtD
Domperidone—Oedema—Procarbazine—brain cancer	0.00112	0.0117	CcSEcCtD
Domperidone—Dysuria—Temozolomide—brain cancer	0.00111	0.0117	CcSEcCtD
Domperidone—Pollakiuria—Temozolomide—brain cancer	0.0011	0.0115	CcSEcCtD
Domperidone—Stomatitis—Carmustine—brain cancer	0.00107	0.0112	CcSEcCtD
Domperidone—Nausea—Lomustine—brain cancer	0.00105	0.011	CcSEcCtD
Domperidone—Hypotension—Procarbazine—brain cancer	0.00105	0.011	CcSEcCtD
Domperidone—Stomatitis—Temozolomide—brain cancer	0.00104	0.0109	CcSEcCtD
Domperidone—Insomnia—Procarbazine—brain cancer	0.00101	0.0106	CcSEcCtD
Domperidone—Somnolence—Procarbazine—brain cancer	0.000996	0.0104	CcSEcCtD
Domperidone—CYP2D6—hindbrain—brain cancer	0.00099	0.0229	CbGeAlD
Domperidone—Constipation—Procarbazine—brain cancer	0.000959	0.01	CcSEcCtD
Domperidone—DRD2—brainstem—brain cancer	0.000944	0.0219	CbGeAlD
Domperidone—DRD3—brain—brain cancer	0.000894	0.0207	CbGeAlD
Domperidone—Urticaria—Procarbazine—brain cancer	0.00089	0.00933	CcSEcCtD
Domperidone—Abdominal pain—Procarbazine—brain cancer	0.000886	0.00928	CcSEcCtD
Domperidone—Arrhythmia—Carmustine—brain cancer	0.000882	0.00924	CcSEcCtD
Domperidone—Oedema—Hydroxyurea—brain cancer	0.000867	0.00909	CcSEcCtD
Domperidone—DRD2—telencephalon—brain cancer	0.000838	0.0194	CbGeAlD
Domperidone—Stomatitis—Etoposide—brain cancer	0.000829	0.00868	CcSEcCtD
Domperidone—KCNH2—telencephalon—brain cancer	0.000825	0.0191	CbGeAlD
Domperidone—Asthenia—Procarbazine—brain cancer	0.000804	0.00843	CcSEcCtD
Domperidone—Pruritus—Procarbazine—brain cancer	0.000793	0.00831	CcSEcCtD
Domperidone—Somnolence—Hydroxyurea—brain cancer	0.000771	0.00808	CcSEcCtD
Domperidone—Diarrhoea—Procarbazine—brain cancer	0.000767	0.00803	CcSEcCtD
Domperidone—Dyspepsia—Hydroxyurea—brain cancer	0.000764	0.008	CcSEcCtD
Domperidone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000757	0.00886	CbGpPWpGaD
Domperidone—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000747	0.00874	CbGpPWpGaD
Domperidone—ABCB1—blood vessel—brain cancer	0.000746	0.0173	CbGeAlD
Domperidone—Constipation—Hydroxyurea—brain cancer	0.000742	0.00777	CcSEcCtD
Domperidone—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000741	0.00868	CbGpPWpGaD
Domperidone—Dizziness—Procarbazine—brain cancer	0.000741	0.00777	CcSEcCtD
Domperidone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00074	0.00866	CbGpPWpGaD
Domperidone—Palpitations—Temozolomide—brain cancer	0.000734	0.00769	CcSEcCtD
Domperidone—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00073	0.00855	CbGpPWpGaD
Domperidone—Vomiting—Procarbazine—brain cancer	0.000713	0.00747	CcSEcCtD
Domperidone—Rash—Procarbazine—brain cancer	0.000707	0.0074	CcSEcCtD
Domperidone—Dermatitis—Procarbazine—brain cancer	0.000706	0.0074	CcSEcCtD
Domperidone—Headache—Procarbazine—brain cancer	0.000702	0.00736	CcSEcCtD
Domperidone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000702	0.00822	CbGpPWpGaD
Domperidone—Oedema—Carmustine—brain cancer	0.000701	0.00735	CcSEcCtD
Domperidone—Dry mouth—Temozolomide—brain cancer	0.000691	0.00724	CcSEcCtD
Domperidone—DRD2—pituitary gland—brain cancer	0.000682	0.0158	CbGeAlD
Domperidone—Oedema—Temozolomide—brain cancer	0.000678	0.0071	CcSEcCtD
Domperidone—KCNH2—pituitary gland—brain cancer	0.000672	0.0156	CbGeAlD
Domperidone—Nausea—Procarbazine—brain cancer	0.000666	0.00697	CcSEcCtD
Domperidone—Hypotension—Carmustine—brain cancer	0.000655	0.00686	CcSEcCtD
Domperidone—KCNH2—medulla oblongata—brain cancer	0.000649	0.015	CbGeAlD
Domperidone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000641	0.0075	CbGpPWpGaD
Domperidone—Muscle spasms—Etoposide—brain cancer	0.000639	0.00669	CcSEcCtD
Domperidone—Insomnia—Carmustine—brain cancer	0.000634	0.00664	CcSEcCtD
Domperidone—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000632	0.0074	CbGpPWpGaD
Domperidone—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000628	0.00736	CbGpPWpGaD
Domperidone—Somnolence—Carmustine—brain cancer	0.000623	0.00653	CcSEcCtD
Domperidone—Asthenia—Hydroxyurea—brain cancer	0.000622	0.00652	CcSEcCtD
Domperidone—CYP2C8—pituitary gland—brain cancer	0.000615	0.0142	CbGeAlD
Domperidone—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000613	0.00718	CbGpPWpGaD
Domperidone—Insomnia—Temozolomide—brain cancer	0.000613	0.00642	CcSEcCtD
Domperidone—Somnolence—Temozolomide—brain cancer	0.000602	0.00631	CcSEcCtD
Domperidone—DRD2—midbrain—brain cancer	0.000602	0.0139	CbGeAlD
Domperidone—Constipation—Carmustine—brain cancer	0.0006	0.00628	CcSEcCtD
Domperidone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.0006	0.00702	CbGpPWpGaD
Domperidone—Dyspepsia—Temozolomide—brain cancer	0.000597	0.00625	CcSEcCtD
Domperidone—Diarrhoea—Hydroxyurea—brain cancer	0.000594	0.00622	CcSEcCtD
Domperidone—KCNH2—midbrain—brain cancer	0.000593	0.0137	CbGeAlD
Domperidone—Constipation—Temozolomide—brain cancer	0.00058	0.00607	CcSEcCtD
Domperidone—KCNH2—spinal cord—brain cancer	0.000578	0.0134	CbGeAlD
Domperidone—Dizziness—Hydroxyurea—brain cancer	0.000574	0.00601	CcSEcCtD
Domperidone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000569	0.00666	CbGpPWpGaD
Domperidone—CYP2D6—brainstem—brain cancer	0.000567	0.0131	CbGeAlD
Domperidone—CYP2B6—gonad—brain cancer	0.000565	0.0131	CbGeAlD
Domperidone—Abdominal pain—Carmustine—brain cancer	0.000554	0.00581	CcSEcCtD
Domperidone—Vomiting—Hydroxyurea—brain cancer	0.000552	0.00578	CcSEcCtD
Domperidone—Rash—Hydroxyurea—brain cancer	0.000547	0.00573	CcSEcCtD
Domperidone—Dermatitis—Hydroxyurea—brain cancer	0.000546	0.00572	CcSEcCtD
Domperidone—Headache—Hydroxyurea—brain cancer	0.000543	0.00569	CcSEcCtD
Domperidone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000542	0.00634	CbGpPWpGaD
Domperidone—Urticaria—Temozolomide—brain cancer	0.000538	0.00564	CcSEcCtD
Domperidone—Abdominal pain—Temozolomide—brain cancer	0.000536	0.00561	CcSEcCtD
Domperidone—DRD2—endocrine gland—brain cancer	0.000528	0.0122	CbGeAlD
Domperidone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000526	0.00616	CbGpPWpGaD
Domperidone—DRD2—head—brain cancer	0.000522	0.0121	CbGeAlD
Domperidone—KCNH2—endocrine gland—brain cancer	0.000521	0.0121	CbGeAlD
Domperidone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000519	0.00608	CbGpPWpGaD
Domperidone—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000519	0.00608	CbGpPWpGaD
Domperidone—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000516	0.00604	CbGpPWpGaD
Domperidone—Nausea—Hydroxyurea—brain cancer	0.000515	0.0054	CcSEcCtD
Domperidone—KCNH2—head—brain cancer	0.000514	0.0119	CbGeAlD
Domperidone—Hypotension—Etoposide—brain cancer	0.000507	0.00531	CcSEcCtD
Domperidone—CYP2D6—telencephalon—brain cancer	0.000503	0.0117	CbGeAlD
Domperidone—Asthenia—Carmustine—brain cancer	0.000503	0.00527	CcSEcCtD
Domperidone—DRD3—Circadian rythm related genes—NTRK3—brain cancer	0.000503	0.00588	CbGpPWpGaD
Domperidone—Asthenia—Temozolomide—brain cancer	0.000486	0.00509	CcSEcCtD
Domperidone—Somnolence—Etoposide—brain cancer	0.000482	0.00505	CcSEcCtD
Domperidone—Diarrhoea—Carmustine—brain cancer	0.00048	0.00503	CcSEcCtD
Domperidone—Pruritus—Temozolomide—brain cancer	0.000479	0.00502	CcSEcCtD
Domperidone—CYP2C8—endocrine gland—brain cancer	0.000476	0.011	CbGeAlD
Domperidone—DRD2—central nervous system—brain cancer	0.000476	0.011	CbGeAlD
Domperidone—KCNH2—central nervous system—brain cancer	0.000469	0.0109	CbGeAlD
Domperidone—DRD2—cerebellum—brain cancer	0.000465	0.0108	CbGeAlD
Domperidone—Dizziness—Carmustine—brain cancer	0.000464	0.00486	CcSEcCtD
Domperidone—Constipation—Etoposide—brain cancer	0.000464	0.00486	CcSEcCtD
Domperidone—Diarrhoea—Temozolomide—brain cancer	0.000464	0.00486	CcSEcCtD
Domperidone—DRD3—GPCRs, Other—SMO—brain cancer	0.000463	0.00542	CbGpPWpGaD
Domperidone—KCNH2—cerebellum—brain cancer	0.000459	0.0106	CbGeAlD
Domperidone—Dizziness—Temozolomide—brain cancer	0.000448	0.00469	CcSEcCtD
Domperidone—Vomiting—Carmustine—brain cancer	0.000446	0.00467	CcSEcCtD
Domperidone—CYP1A2—endocrine gland—brain cancer	0.000446	0.0103	CbGeAlD
Domperidone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000446	0.00522	CbGpPWpGaD
Domperidone—Rash—Carmustine—brain cancer	0.000442	0.00463	CcSEcCtD
Domperidone—Dermatitis—Carmustine—brain cancer	0.000442	0.00463	CcSEcCtD
Domperidone—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000441	0.00516	CbGpPWpGaD
Domperidone—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00044	0.00515	CbGpPWpGaD
Domperidone—Headache—Carmustine—brain cancer	0.000439	0.0046	CcSEcCtD
Domperidone—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000435	0.00509	CbGpPWpGaD
Domperidone—Vomiting—Temozolomide—brain cancer	0.000431	0.00451	CcSEcCtD
Domperidone—Urticaria—Etoposide—brain cancer	0.000431	0.00451	CcSEcCtD
Domperidone—CYP3A5—endocrine gland—brain cancer	0.00043	0.00996	CbGeAlD
Domperidone—Abdominal pain—Etoposide—brain cancer	0.000429	0.00449	CcSEcCtD
Domperidone—CYP2B6—endocrine gland—brain cancer	0.000427	0.0099	CbGeAlD
Domperidone—Rash—Temozolomide—brain cancer	0.000427	0.00448	CcSEcCtD
Domperidone—Dermatitis—Temozolomide—brain cancer	0.000427	0.00447	CcSEcCtD
Domperidone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000426	0.00499	CbGpPWpGaD
Domperidone—Headache—Temozolomide—brain cancer	0.000425	0.00445	CcSEcCtD
Domperidone—CYP2B6—head—brain cancer	0.000422	0.00977	CbGeAlD
Domperidone—Nausea—Carmustine—brain cancer	0.000417	0.00436	CcSEcCtD
Domperidone—Nausea—Temozolomide—brain cancer	0.000403	0.00422	CcSEcCtD
Domperidone—Asthenia—Etoposide—brain cancer	0.000389	0.00408	CcSEcCtD
Domperidone—CYP2B6—central nervous system—brain cancer	0.000385	0.00892	CbGeAlD
Domperidone—DRD2—Circadian rythm related genes—NTRK3—brain cancer	0.000385	0.0045	CbGpPWpGaD
Domperidone—Pruritus—Etoposide—brain cancer	0.000384	0.00402	CcSEcCtD
Domperidone—DRD2—brain—brain cancer	0.000378	0.00876	CbGeAlD
Domperidone—KCNH2—brain—brain cancer	0.000373	0.00863	CbGeAlD
Domperidone—Diarrhoea—Etoposide—brain cancer	0.000371	0.00389	CcSEcCtD
Domperidone—ABCB1—telencephalon—brain cancer	0.000362	0.00839	CbGeAlD
Domperidone—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000361	0.00423	CbGpPWpGaD
Domperidone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.00036	0.00421	CbGpPWpGaD
Domperidone—Dizziness—Etoposide—brain cancer	0.000359	0.00376	CcSEcCtD
Domperidone—KCNH2—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000353	0.00413	CbGpPWpGaD
Domperidone—Vomiting—Etoposide—brain cancer	0.000345	0.00361	CcSEcCtD
Domperidone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000344	0.00403	CbGpPWpGaD
Domperidone—Rash—Etoposide—brain cancer	0.000342	0.00358	CcSEcCtD
Domperidone—Dermatitis—Etoposide—brain cancer	0.000342	0.00358	CcSEcCtD
Domperidone—CYP2C8—brain—brain cancer	0.000341	0.0079	CbGeAlD
Domperidone—Headache—Etoposide—brain cancer	0.00034	0.00356	CcSEcCtD
Domperidone—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000339	0.00397	CbGpPWpGaD
Domperidone—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000326	0.00382	CbGpPWpGaD
Domperidone—CYP3A4—endocrine gland—brain cancer	0.000323	0.00748	CbGeAlD
Domperidone—Nausea—Etoposide—brain cancer	0.000322	0.00337	CcSEcCtD
Domperidone—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000321	0.00376	CbGpPWpGaD
Domperidone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000321	0.00375	CbGpPWpGaD
Domperidone—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000319	0.00373	CbGpPWpGaD
Domperidone—CYP2D6—endocrine gland—brain cancer	0.000318	0.00736	CbGeAlD
Domperidone—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000314	0.00368	CbGpPWpGaD
Domperidone—CYP2D6—head—brain cancer	0.000313	0.00726	CbGeAlD
Domperidone—CYP2B6—brain—brain cancer	0.000306	0.00708	CbGeAlD
Domperidone—ABCB1—gonad—brain cancer	0.000302	0.007	CbGeAlD
Domperidone—ABCB1—pituitary gland—brain cancer	0.000295	0.00683	CbGeAlD
Domperidone—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000292	0.00342	CbGpPWpGaD
Domperidone—CYP3A4—central nervous system—brain cancer	0.000291	0.00674	CbGeAlD
Domperidone—CYP2D6—central nervous system—brain cancer	0.000286	0.00663	CbGeAlD
Domperidone—ABCB1—medulla oblongata—brain cancer	0.000285	0.00659	CbGeAlD
Domperidone—CYP2D6—cerebellum—brain cancer	0.00028	0.00648	CbGeAlD
Domperidone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000279	0.00326	CbGpPWpGaD
Domperidone—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000276	0.00323	CbGpPWpGaD
Domperidone—KCNH2—SIDS Susceptibility Pathways—HES1—brain cancer	0.000274	0.0032	CbGpPWpGaD
Domperidone—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000272	0.00319	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—PTCH2—brain cancer	0.000269	0.00314	CbGpPWpGaD
Domperidone—ABCB1—midbrain—brain cancer	0.00026	0.00602	CbGeAlD
Domperidone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000259	0.00303	CbGpPWpGaD
Domperidone—ABCB1—spinal cord—brain cancer	0.000254	0.00588	CbGeAlD
Domperidone—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000238	0.00278	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—OR4C12—brain cancer	0.000235	0.00276	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—OR14C36—brain cancer	0.000235	0.00276	CbGpPWpGaD
Domperidone—ABCB1—endocrine gland—brain cancer	0.000228	0.00529	CbGeAlD
Domperidone—CYP2D6—brain—brain cancer	0.000227	0.00526	CbGeAlD
Domperidone—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000226	0.00265	CbGpPWpGaD
Domperidone—ABCB1—head—brain cancer	0.000225	0.00522	CbGeAlD
Domperidone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000224	0.00263	CbGpPWpGaD
Domperidone—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000223	0.00262	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—OR4C12—brain cancer	0.000214	0.0025	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—OR14C36—brain cancer	0.000214	0.0025	CbGpPWpGaD
Domperidone—ABCB1—central nervous system—brain cancer	0.000206	0.00477	CbGeAlD
Domperidone—DRD2—GPCR ligand binding—PTCH2—brain cancer	0.000205	0.00241	CbGpPWpGaD
Domperidone—ABCB1—cerebellum—brain cancer	0.000201	0.00466	CbGeAlD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000198	0.00232	CbGpPWpGaD
Domperidone—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000192	0.00225	CbGpPWpGaD
Domperidone—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000189	0.00222	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—OR4C12—brain cancer	0.00018	0.00211	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—OR14C36—brain cancer	0.00018	0.00211	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—SIRT1—brain cancer	0.000167	0.00195	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—OR14C36—brain cancer	0.000164	0.00192	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—OR4C12—brain cancer	0.000164	0.00192	CbGpPWpGaD
Domperidone—ABCB1—brain—brain cancer	0.000163	0.00379	CbGeAlD
Domperidone—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000153	0.00179	CbGpPWpGaD
Domperidone—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000148	0.00173	CbGpPWpGaD
Domperidone—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000146	0.00171	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—SHH—brain cancer	0.000138	0.00162	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—PTCH2—brain cancer	0.000138	0.00161	CbGpPWpGaD
Domperidone—KCNH2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000137	0.00161	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—SMO—brain cancer	0.000131	0.00154	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—PTCH1—brain cancer	0.000131	0.00154	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000128	0.0015	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—SIRT1—brain cancer	0.000128	0.00149	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—OR4C12—brain cancer	0.000126	0.00148	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—OR14C36—brain cancer	0.000126	0.00148	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—CDK4—brain cancer	0.000126	0.00148	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000121	0.00142	CbGpPWpGaD
Domperidone—KCNH2—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000121	0.00142	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—ABR—brain cancer	0.000119	0.00139	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000114	0.00134	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—ABR—brain cancer	0.000108	0.00127	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—DTX2—brain cancer	0.000107	0.00126	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000106	0.00124	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000106	0.00124	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—SHH—brain cancer	0.000106	0.00124	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PTCH2—brain cancer	0.000105	0.00123	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000103	0.0012	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000102	0.0012	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—PTCH1—brain cancer	0.0001	0.00117	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—SMO—brain cancer	0.0001	0.00117	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—OR14C36—brain cancer	9.67e-05	0.00113	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—OR4C12—brain cancer	9.67e-05	0.00113	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—CDK4—brain cancer	9.65e-05	0.00113	CbGpPWpGaD
Domperidone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	9.57e-05	0.00112	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—ABR—brain cancer	9.11e-05	0.00107	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	8.74e-05	0.00102	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	8.39e-05	0.000983	CbGpPWpGaD
Domperidone—ABCB1—Allograft Rejection—IL2—brain cancer	8.36e-05	0.000978	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—ABR—brain cancer	8.27e-05	0.000969	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	8.23e-05	0.000964	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—DTX2—brain cancer	8.22e-05	0.000962	CbGpPWpGaD
Domperidone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	8.2e-05	0.00096	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PTCH2—brain cancer	8.14e-05	0.000953	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	8.13e-05	0.000952	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	8.04e-05	0.000941	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—HES5—brain cancer	7.88e-05	0.000923	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	7.86e-05	0.000921	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	7.86e-05	0.000921	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.75e-05	0.000907	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—STRADA—brain cancer	7.65e-05	0.000896	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	7.56e-05	0.000885	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—TRPC6—brain cancer	7.54e-05	0.000883	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—CYP2C9—brain cancer	7.54e-05	0.000882	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.37e-05	0.000863	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	7.2e-05	0.000843	CbGpPWpGaD
Domperidone—ABCB1—Allograft Rejection—VEGFA—brain cancer	7.1e-05	0.000831	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—SHH—brain cancer	7.1e-05	0.000831	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—TRPC6—brain cancer	6.85e-05	0.000801	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—SMO—brain cancer	6.73e-05	0.000788	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—PTCH1—brain cancer	6.73e-05	0.000788	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—BSG—brain cancer	6.41e-05	0.00075	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—ABR—brain cancer	6.39e-05	0.000748	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PTCH2—brain cancer	6.23e-05	0.000729	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	6.23e-05	0.000729	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—GLI2—brain cancer	6.17e-05	0.000722	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HES5—brain cancer	6.03e-05	0.000706	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	5.86e-05	0.000686	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—STRADA—brain cancer	5.86e-05	0.000686	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—GLI1—brain cancer	5.8e-05	0.000679	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—TRPC6—brain cancer	5.77e-05	0.000675	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—VAV1—brain cancer	5.65e-05	0.000661	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CYP2C9—brain cancer	5.57e-05	0.000652	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—IDH1—brain cancer	5.51e-05	0.000645	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SUFU—brain cancer	5.5e-05	0.000644	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CYP2C9—brain cancer	5.45e-05	0.000638	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—SHH—brain cancer	5.43e-05	0.000636	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.39e-05	0.000631	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—TP53—brain cancer	5.37e-05	0.000628	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—GFAP—brain cancer	5.31e-05	0.000621	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—TRPC6—brain cancer	5.24e-05	0.000613	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PTCH1—brain cancer	5.15e-05	0.000603	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—SMO—brain cancer	5.15e-05	0.000603	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—VAV1—brain cancer	5.13e-05	0.000601	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—HEY1—brain cancer	5.03e-05	0.000589	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—DLL1—brain cancer	4.93e-05	0.000577	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	4.89e-05	0.000573	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ABR—brain cancer	4.89e-05	0.000572	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—BSG—brain cancer	4.74e-05	0.000555	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—GLI2—brain cancer	4.72e-05	0.000553	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CYP2C9—brain cancer	4.72e-05	0.000552	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—BSG—brain cancer	4.63e-05	0.000542	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	4.55e-05	0.000533	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—GLI1—brain cancer	4.44e-05	0.00052	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—ENO2—brain cancer	4.36e-05	0.00051	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—VAV1—brain cancer	4.32e-05	0.000506	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SUFU—brain cancer	4.21e-05	0.000493	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SHH—brain cancer	4.19e-05	0.000491	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYP2C9—brain cancer	4.11e-05	0.000481	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—TP53—brain cancer	4.11e-05	0.000481	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—IDH1—brain cancer	4.07e-05	0.000477	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—GFAP—brain cancer	4.06e-05	0.000475	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TRPC6—brain cancer	4.04e-05	0.000473	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.02e-05	0.000471	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—BSG—brain cancer	4.01e-05	0.00047	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—IDH1—brain cancer	3.98e-05	0.000466	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.98e-05	0.000466	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SMO—brain cancer	3.98e-05	0.000465	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PTCH1—brain cancer	3.98e-05	0.000465	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—VAV1—brain cancer	3.92e-05	0.00046	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP2C9—brain cancer	3.87e-05	0.000453	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HEY1—brain cancer	3.85e-05	0.000451	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—DLL1—brain cancer	3.77e-05	0.000442	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—PIK3CG—brain cancer	3.59e-05	0.00042	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.5e-05	0.00041	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—BSG—brain cancer	3.49e-05	0.000409	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—IDH1—brain cancer	3.45e-05	0.000404	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—BSG—brain cancer	3.29e-05	0.000386	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP2C9—brain cancer	3.28e-05	0.000384	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—PIK3CG—brain cancer	3.26e-05	0.000381	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.22e-05	0.000378	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ENO2—brain cancer	3.22e-05	0.000377	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SHH—brain cancer	3.21e-05	0.000376	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NOTCH2—brain cancer	3.18e-05	0.000372	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.15e-05	0.000369	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ENO2—brain cancer	3.15e-05	0.000369	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TRPC6—brain cancer	3.09e-05	0.000362	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SMO—brain cancer	3.04e-05	0.000356	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PTCH1—brain cancer	3.04e-05	0.000356	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—VAV1—brain cancer	3.03e-05	0.000355	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—IDH1—brain cancer	3.01e-05	0.000352	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—IDH1—brain cancer	2.83e-05	0.000332	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.81e-05	0.000329	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—BSG—brain cancer	2.79e-05	0.000327	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—PIK3CG—brain cancer	2.74e-05	0.000321	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ENO2—brain cancer	2.73e-05	0.000319	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.65e-05	0.00031	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—HES1—brain cancer	2.61e-05	0.000305	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP2C9—brain cancer	2.53e-05	0.000296	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—IL2—brain cancer	2.52e-05	0.000295	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PIK3CG—brain cancer	2.49e-05	0.000292	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PDGFRA—brain cancer	2.48e-05	0.00029	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NOTCH2—brain cancer	2.43e-05	0.000285	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SPP1—brain cancer	2.41e-05	0.000282	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—IDH1—brain cancer	2.4e-05	0.000281	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ENO2—brain cancer	2.38e-05	0.000278	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—VAV1—brain cancer	2.32e-05	0.000271	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL2—brain cancer	2.29e-05	0.000268	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ENO2—brain cancer	2.24e-05	0.000262	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IRS2—brain cancer	2.18e-05	0.000255	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—BSG—brain cancer	2.15e-05	0.000252	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CG—brain cancer	2e-05	0.000234	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HES1—brain cancer	1.99e-05	0.000233	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.95e-05	0.000229	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—IL2—brain cancer	1.93e-05	0.000226	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CG—brain cancer	1.92e-05	0.000225	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—APC—brain cancer	1.92e-05	0.000225	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PDGFRA—brain cancer	1.9e-05	0.000222	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ENO2—brain cancer	1.9e-05	0.000222	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—IDH1—brain cancer	1.85e-05	0.000217	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SPP1—brain cancer	1.84e-05	0.000216	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL2—brain cancer	1.75e-05	0.000205	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—EGFR—brain cancer	1.75e-05	0.000205	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IRS2—brain cancer	1.67e-05	0.000195	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—RELA—brain cancer	1.5e-05	0.000176	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—ERBB2—brain cancer	1.49e-05	0.000175	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CG—brain cancer	1.48e-05	0.000173	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.47e-05	0.000172	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—APC—brain cancer	1.47e-05	0.000172	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ENO2—brain cancer	1.46e-05	0.000171	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CG—brain cancer	1.44e-05	0.000169	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL2—brain cancer	1.35e-05	0.000159	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—EGFR—brain cancer	1.34e-05	0.000157	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCND1—brain cancer	1.32e-05	0.000155	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CTNNB1—brain cancer	1.31e-05	0.000153	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CG—brain cancer	1.25e-05	0.000146	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—VEGFA—brain cancer	1.15e-05	0.000135	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—RELA—brain cancer	1.15e-05	0.000135	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ERBB2—brain cancer	1.14e-05	0.000134	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—STAT3—brain cancer	1.14e-05	0.000133	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CG—brain cancer	1.09e-05	0.000128	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MYC—brain cancer	1.06e-05	0.000124	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL2—brain cancer	1.04e-05	0.000121	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EGFR—brain cancer	1.04e-05	0.000121	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CG—brain cancer	1.03e-05	0.00012	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCND1—brain cancer	1.01e-05	0.000118	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CTNNB1—brain cancer	1e-05	0.000117	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—VEGFA—brain cancer	8.8e-06	0.000103	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—STAT3—brain cancer	8.72e-06	0.000102	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CG—brain cancer	8.7e-06	0.000102	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TP53—brain cancer	8.69e-06	0.000102	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MYC—brain cancer	8.1e-06	9.48e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EGFR—brain cancer	7.92e-06	9.28e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CG—brain cancer	6.71e-06	7.86e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TP53—brain cancer	6.65e-06	7.79e-05	CbGpPWpGaD
